On August 7, 2012, Shirley Wang wrote in the Wall Street Journal about recent advancements in the research for a migraine cure. In particular, she wrote that researchers have isolated a brain chemical, known as calcitonin gene-related peptide transmitter (“CGRP”) to be responsible for the transmission of migraine pain. She further wrote that researchers are in the process of coming up with medicines that would block CGRP from forming and thus prohibit any migraine pain from occurring. Several doctors were quoted in the article and one of the so-called experts stated that there was an immediate need to develop drugs that would stop any pain from being felt by migraine sufferers.
No more posts.